Artikels
2022
- Whole blood donor return rates after deferral for tattooing or body piercing-Survey across blood donation services; The BEST collaborative study.
Quee F, O'Brien SF, Prinsze F, Steele WR, Grégoire Y, Cutajar A, Wendel S, Compernolle V, Goldman M, van den Hurk K; Biomedical Excellence for Safer Transfusion (BEST) Collaborative - Single step method for high yield human platelet lysate production
Delabie W, De Bleser D, Vandewalle V, Vandekerckhove Ph, Compernolle V and Feys HB - ADAMTS13 inhibition to treat acquired von Willebrand syndrome during mechanical circulatory support device implantation
Deconinck SJ, Nix C, Barth S, Bennek-Schöpping E, Rauch A, Schelpe AS, Roose E, Feys HB, Pareyn I, Vandenbulcke A, Muia J, Vandenbriele C, Susen S, Meyns B, Tersteeg C, Jacobs S, De Meyer SF and Vanhoorelbeke K - Multinational analysis of children transfused with pathogen inactivated platelets
Delaney M, Andrews J, Virk M, Barber JR, Bost JE, Baech J and Feys HB - Detection and characterization of a novel HLA-C partial deletion-inversion in two unrelated do-nor samples using hybrid capture
Van Sandt V, Kerkhofs J, Depelsmaeker S, Emonds M P, Madden L, Edwards J, Hogan H, Kyle P, Newbound C - Association of HLA Mismatches and Histology Suggestive of Antibody-Mediated Injury in the Absence of Donor-Specific Anti-HLA Antibodies
Senev A, Lerut E, Coemans M, Callemeyn J, Copley H C, Claas F, Koshy P, Vasilis Kosmoliaptsis, Kuypers D, Sprangers B,
Van Craenenbroeck A, Van Loon E, Van Sandt V, Emonds M P, Naesens M - Association of Predicted HLA T-Cell Epitope Targets and T-Cell–Mediated Rejection After Kidney Transplantation
Senev A, Van Loon E, Lerut E, Coemans M, Callemeyn J, Daniëls L, Kerkhofs J, Koshy P, Kuypers D, Lamarthee B, Sprangers B, Tinel C, Van Craenenbroeck AH, Van Sandt V, Emonds MP, and Naesens M - Preexisting memory CD4 T cells in naive individuals confer robust immunity upon hepatitis B vaccination
Elias G, Meysman P, Bartholomeus E, De Neuter N, Keersmaekers N, Suls A, Jansens H, Souquette A, De Reu H, Emonds M P, Smits E, Lion E, Thomas P G, Mortier G, Van Damme P, Beutels P, Laukens K, Van Tendeloo V, Ogunjimi B - The Pre-Transplant Non-HLA Antibody Burden Associates With the Development of Histology of Antibody-Mediated Rejection After Kidney Transplantation
Senev A, Ray B, Lerut E, Hariharan J, Heylen C, Kuypers D, Sprangers B, Emonds M P, Naesens M - Circulating Donor-Specific Anti-HLA Antibodies Associate With Immune Activation Independent of Kidney Transplant Histopathological Findings
Van Loon E, Lamarthe B, Barba T, Claes S, Coemans M, de Loor H, Emonds M P, Koshy P, Kuypers D, Proost P, Senev A, Sprangers B, Tinel C, Thaunat O, Van Craenenbroeck A H, Schols D, Naesens M - Data-Driven Chronic Allograft Phenotypes: A Novel and Validated Complement for Histologic Assessment of Kidney Transplant Biopsies
Vaulet T, Divard G, Thaunat O, Priyanka Koshy P, Lerut E, Senev A, Aubert O, Van Loon E, Callemeyn J, Emonds M P, Van Craenenbroeck A, De Vusser K, Sprangers B, Rabeyrin M, Dubois V, Kuypers D, De Vos M, Loupy A, De Moor B, Naesens M - Allogeneic Hematopoietic Stem Cell Transplantation After Prior Lung Transplantation for Heredi-tary Pulmonary Alveolar Proteinosis: A Case Report.
Beeckmans H, Ambrocio G P L, Bos S, Vermaut A, Geudens V, Vanstapel A, Vanaudenaerde B M, De Baets F, Malfait T L A, Emonds M P, Van Raemdonck D E, Schoemans H M, Vos R - Early high antibody-titre convalescent plasma for hospitalised COVID-19 patients; DAWn-plasma
Devos T, Van Thillo Q, Compernolle V, Najdovski T, Romano M, Dauby N, Jadot L, Leys M, Maillart E, Loof S, Seyler L, Moonen M, Moutschen M, Van Regenmortel N, Ariën KK, Barbezange C, Betrains A, Garigliany M, Engelen MM, Gyselinck I, Maes P, Schauwvlieghe A, Liesenborghs L, Belmans A, Verhamme P, Meyfroidt G, DAWn-plasma investigators
2021
- Forecasting of patient-specific kidney transplant function with a sequence-to-sequence deep learning model
Van Loon E, Zhang W, Coemans M, De Vos M, Emonds M-P, Scheffner I, Gwinner W, Kuypers D, Senev A, Tinel C, Van Craenenbroeck A H, De Moor B, Naesens M - Hepatitis B virus prevalence in first-time blood donors in Flanders, Belgium: Impact of universal vaccination and migration
De Brier N, Koc O M, De Buck E, Muylaert A, Nevens F, Vanbrabant M, Vandeloo J, Van Remoortel H, Robaeys G, Compernolle V - The role of HLA-DP mismatches and donor specific HLA-DP antibodies in kidney transplantation: a case series
Daniëls L, Claas F, Kramer C, Senev A, Vanden Driessche M, Emonds M-P, Van Laecke S, Hellemans R, Abramowicz D, Naesens M - Risk factors, histopathological features, and graft outcome of transplant glomerulopathy in the absence of donor-specific HLA antibodies
Senev A, Van Loon E, Lerut E, Callemeyn J, Coemans M, Van Sandt V, Kuypers D, Emonds M-P, Naesens M
2020
- Antibodies Against ARHGDIB and ARHGDIB Gene Expression Associate With Kidney Allograft Outcome
Senev A, Otten H G , Kamburova E G , Callemeyn J, Lerut E, Van Sandt V , Kuypers D, Emonds M-P, Naesens M - Eplet Mismatch Load and De Novo Occurrence of Donor-Specific Anti-HLA Antibodies, Rejection, and Graft Failure after Kidney Transplantation: An Observational Cohort Study
Senev A, Coemans M, Lerut E, Van Sandt V, Kerkhofs J, Daniëls L, Vanden Driessche M, Compernolle V, Sprangers B, Van Loon E, Callemeyn J, Claas F, Tambur A R, Verbeke G, Kuypers D, Emonds M-P, Naesens M - Clinical importance of extended second field high-resolution HLA genotyping for kidney transplantation
Senev A, Emonds M-P, Van Sandt V, Lerut E, Coemans M, Sprangers B, Kuypers D, Naesens M - Haalbaarheid van actieve contact tracing van Covid-19- infecties in de eerstelijnszorg: een pilootproject
Ostyn B, Joye T, Muylaert A, Vanbrabant M, Delespau A - Antibody-mediated rejection with and without donor-specific anti-human leucocyte antigen antibodies: performance of the peripheral blood 8-gene expression assay
Van Loon E, Lerut E, de Loor H, Kuypers D, Emonds M-P, Anglicheau D, Gwinner W, Essig M, Marquet P, Naesens M - The Histological Picture of Indication Biopsies in the First 2 Weeks after Kidney Transplantation
Van Loon E, Lerut E, Senev A, Coemans M, Pirenne J, Monbaliu D, Jochmans I, Sainz Barriga M, De Vusser K, Van Craenenbroeck A, Sprangers B, Emonds M-P, Kuypers D, Naesens M - HLA Class II Genotype Does Not Affect the Myelin Responsiveness of Multiple Sclerosis Patients
Derdelinckx J, Nkansah I, Ooms N, Van Bruggen L, Emonds M-P, Daniëls L, Reynders T, Willekens B, Cras P, Berneman Z, Cools N
2019
- HLA class II antibodies at the time of kidney transplantation and cardiovascular outcome: a retrospective cohort study
Malfait T, Emonds MP, Daniëls L, Nagler EV, Van Biesen W, Van Laecke S - Intragraft donor-specific anti-HLA antibodies in pheno-types of chronic lung allograft dysfunction
Sacreas A, Taupin JL, Emonds MP, Daniëls L, Van Raemdonck DE, Vos R, Verleden GM, Vanaudenaerde BM, Roux A, Verleden SE; Leuven Lung Transplant Group - The clinical significance of epitope mismatch load in kidney transplantation: A multicentre study
Daniëls L, Naesens M, Bosmans JL, Abramowicz D, Nagler E, Van Laecke S, Peeters P, Kuypers D, Emonds MP - Are we underestimating reverse TRALI?
De Clippel D, Emonds M-P, Compernolle V. - Histological picture of antibody‐mediated rejection without donor‐specific anti‐HLA antibodies: Clinical presentation and implications for outcome
Senev A., Coemans M., Lerut E., Van Sandt V., Daniëls L., Kuypers D., Sprangers B., Emonds MP., Naesens M. - Specificity, strength, and evolution of pretransplant donor‐specific HLA antibodies determine outcome after kidney transplantation
Senev A., Lerut E., Van Sandt V., Coemans M., Callemeyn J., Sprangers B., Kuypers D., Emonds MP., Naesens M. - Antibodies against ARHGDIB and ARHGDIB gene expression associate with kidney allograft outcome.
Senev A., Otten H., Kamburova E., Callemeyn J., Lerut E., Van Sandt V., Kuypers D., Emonds M., Naesens, M.
2018
- The clinical significance of epitope mismatch load in kidney transplantation: A multicentre study
L. Daniëls, M. Naesens, JL. Bosmans, D. Abramowiczb, E. Nagler, S. Van Laecke, P. Peeters, D. Kuypers, MP. Emonds
Laatst aangepast op 24/01/23.
Newsletter
De websites van Rode Kruis-Vlaanderen maken gebruik van cookies om jouw bezoek zo vlot mogelijk te laten verlopen. We installeren noodzakelijke en technische cookies voor het goed functioneren van deze websites. Daarnaast gebruiken we analytische en advertising cookies om het algemeen gebruik van de websites te meten en verbeteren. Geef hieronder aan dat je akkoord bent met ons cookiebeleid om verder te surfen.